1. Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyamaetal. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society // Esophagus. 2015. Vol. 12. P. 1–30.
2. Hulscher J.B., Tijssen J.G., Obertop H., van Lanschot J.J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis // Ann. Thorac. Surg. 2001. Vol. 72, N 1. P. 306–313.
3. Altorki N., Kent M., Ferrara C., Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus // Ann. Surg. 2002. Vol. 236, N 2. P. 177–183.
4. Kelsen D.P., Winter K.A., Gunderson L.L. et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer // J. Clin. Oncol. 2007. Vol. 25, N 24. P. 3719–3725.
5. Almhanna K., Strosberg J.R. Multimodality approach for locally advanced esophageal cancer // World J. Gastroenterol. 2012. Vol. 18, N 40. P. 5679–5687.
6. Peyre C.G., Hagen J.A., DeMeester S.R. et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes // Ann. Surg. 2008. Vol. 248, N 6. P. 979–985.
7. Давыдов М.И., Бохян В.Ю., Стилиди И.С. и др. Внутриплевральная толстокишечная пластика в хирургии рака грудного отдела пищевода // Сибирский онкологический журнал. 2004. Т. 2–3, № 10–11. С. 48–54.
8. Campbell N.P., Villaflor V.M. Neoadjuvant treatment of esophageal cancer //World J. Gastroenterol. 2010. Vol. 16, N 30. P. 3793–3803.
9. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial // Lancet. 2002. Vol. 359, N 9319. P. 1727–1733.
10. Allum W.H., Stenning S.P., Bancewicz J. et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer // J. Clin. Oncol. 2009. Vol. 27. P. 5062–5067.
11. Ronan J.K. Emerging Multimodality Approaches toTreat Localized Esophageal Cancer // JNCCN Journal of the National Comprehensive Cancer Network. 2019. Vol. 17, N 8. Р. 1009–1014.
12. Kelsen D.P., Ginsberg R., Pajak T.F. et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer // N. Engl. J. Med. 1998. Vol. 339. P. 1979–1984.
13. Alderson D., Cunningham D., Nankivell M. et al. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial // Lancet Oncol. 2017.Vol. 18, № 9. P. 1249–1260.
14. Boonstra J.J., Kok T.C., Wijnhoven B.P. et al. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial // BMC Cancer. 2011. Vol. 11. P. 181.
15. Cunningham D., Stenning S., Smyth E. et al. Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03). Primary analysis results of a multicentre, open-label, randomised phase 2–3 trial // Lancet Oncol. 2017. Vol. 18, N 3. P. 357–370.
16. Urschel J.D., Vasan H., Blewett C.J. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer // Am. J. Surg. 2002. Vol. 183, N 3. P. 274–279.
17. Malthaner R., Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer // Cochrane Database Syst. Rev. 2003. Vol. 4. CD001556.
18. Hirao M., Ando N., Tsujinaka T. et al. Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications // Br. J. Surg. 2011. Vol. 98. P. 1735–1741.
19. Sjoquist K.M., Burmeister B.H., Smithers B.M. et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectableoesophageal carcinoma: an updated meta-analysis // Lancet Oncol. 2011. Vol. 12, N 7. P. 681–692.